JPRN-jRCTb050220120招募中1 期
An open-label study on the safety of adipose tissue-derived stem cell (ADSCs) transplantation for pain relief from lumbar spinal stenosis - OL-ADSC-TP-LSS
Sobajima Satoshi0 个研究点目标入组 5 人开始时间: 2022年11月21日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who have been diagnosed with lumbar spinal stenosis and whose affected area can be identified by clinical examinations.
- •- Being 20 years old or older at the time of obtaining consent
- •- No improvement in standard conservative therapy covered by insurance
- •- Do not request surgical treatment at the time of obtaining consent
- •- After receiving sufficient explanation about this research, consent should be obtained in writing from the person himself.
- •- Being able to comply with the set schedule
排除标准
- •Patients who meet any of the following criteria will be excluded from this trial.
- •- Patients who have difficulty in subcutaneous liposuction
- •- Patients whose causative lesion is difficult to identify by preoperative examination
- •- Patients with cancer
- •- Patients using anticancer drugs, biopharmacy or immunosuppressants
- •- Patients with active infection
- •- Patients who have received this treatment within 1 month
- •- Patients with serious complications (heart disease, lung disease, liver disease, kidney disease, bleeding tendency, uncontrolled diabetes and hypertension, etc.) that the attending physician or regenerative medicine provider deems inappropriate
- •- Patients with a history of drug hypersensitivity to anesthetics, etc.
- •- Other patients who the doctor in charge deems inappropriate
研究者
相似试验
未知
1 期
Open-label study to assess safety, pharmacokinetics and exposed dose of NMK20 in healthy Japanese male subjectsHealthy Japanese male subjectsJPRN-jRCT2080222333ihon Medi-Physics Co., Ltd.6
尚未招募
4 期
To evaluate the effect of PentaSure fibersupplementation in the management of Functional Constipation among ChildreCTRI/2023/10/058430Hexagon Nutrition Limited
进行中（未招募）
不适用
An open label study on safety and pharmacokinetics of an intravenous administered single dose of Feramyl 200 mg in healthy blood donors compared to a single dose of Feramyl 1000 mg in IBD patients to evaluate dose dependency and kinetics after 1 hour infusion.EUCTR2013-001123-39-DKSerumWerk Bernburg AG16
进行中（未招募）
1 期
An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)Children and adolescents aged 1-17 years at diagnosis, with Ph+ALLMedDRA version: 14.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 100000004864EUCTR2004-001647-30-ITA.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA550
已完成
不适用
A clinical study to test the safety and the efficacy of a single-pill combination of 2 antihypertensive and 1 lipid-lowering drug in patients already well treated with the concomitant administration of the same three drugs on separate tabletsHypertension and dyslipidemiaCirculatory SystemISRCTN27159806Institut de Recherche Internationales Servier130